drugset / Press release
Emergent BioSolutions to Acquire Raxibacumab, an FDA-Approved Anthrax Monoclonal Antibody, From GSK
2017-07-19 · Emergent BioSolutions · original emergentbiosolutions.com ↗
071917 - EBS to Acquire Raxibacumab FINAL.pdf 72.8 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗